Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.44B
Enterprise Value4.32B
P/E Ratio210.61
PEG Ratio-2.65
Price/Sales Ratio2.06
Price/Book Ratio1.85
Enterprise/Revenue2.08
Enterprise/EBITDA18.49

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue2.91B
Revenue/Share2.5
Gross Profit1.19B
EBITDA438.29M
Net Income70.56M
Diluted EPS0.07

Balance Sheet

Total Cash702.57M
Total Cash/Share0.64
Total Debt757.35M
Total Debt/Equity0.25
Current Ratio2.08
Book Value Per Share3.58

Price History

52-Week Change10.97
52-Week High8.44
52-Week Low3.68
Moving Average 50 Days5.25
Moving Average 200 Days4.87

Statistics

Average Volume119.01M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield1.01
Payout Ratio4.6
Last Split Factor3:2
Last Split DateMarch 13, 2013
AD